AbbVie, Inc. (ABBV)
257.07
+2.07
(+0.81%)
USD |
NYSE |
Sep 11, 14:42
AbbVie Gross Profit (TTM) : 45.98B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.98B |
| March 31, 2026 | 44.34B |
| December 31, 2025 | 42.89B |
| September 30, 2025 | 41.56B |
| June 30, 2025 | 41.39B |
| March 31, 2025 | 40.62B |
| December 31, 2024 | 39.50B |
| September 30, 2024 | 38.80B |
| June 30, 2024 | 38.12B |
| March 31, 2024 | 37.53B |
| December 31, 2023 | 38.24B |
| September 30, 2023 | 39.22B |
| June 30, 2023 | 40.24B |
| March 31, 2023 | 40.98B |
| December 31, 2022 | 41.56B |
| September 30, 2022 | 41.17B |
| June 30, 2022 | 40.59B |
| March 31, 2022 | 39.65B |
| December 31, 2021 | 38.97B |
| September 30, 2021 | 37.78B |
| June 30, 2021 | 35.61B |
| March 31, 2021 | 32.88B |
| December 31, 2020 | 30.72B |
| September 30, 2020 | 27.93B |
| June 30, 2020 | 26.59B |
| Date | Value |
|---|---|
| March 31, 2020 | 26.24B |
| December 31, 2019 | 25.66B |
| September 30, 2019 | 25.31B |
| June 30, 2019 | 25.25B |
| March 31, 2019 | 25.24B |
| December 31, 2018 | 25.20B |
| September 30, 2018 | 24.69B |
| June 30, 2018 | 23.58B |
| March 31, 2018 | 22.56B |
| December 31, 2017 | 21.41B |
| September 30, 2017 | 20.86B |
| June 30, 2017 | 20.44B |
| March 31, 2017 | 20.10B |
| December 31, 2016 | 19.82B |
| September 30, 2016 | 19.41B |
| June 30, 2016 | 19.18B |
| March 31, 2016 | 18.65B |
| December 31, 2015 | 18.10B |
| September 30, 2015 | 17.62B |
| June 30, 2015 | 16.92B |
| March 31, 2015 | 16.25B |
| December 31, 2014 | 15.65B |
| September 30, 2014 | 15.12B |
| June 30, 2014 | 14.70B |
| March 31, 2014 | 14.51B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Biogen, Inc. | 6.211B |
| Gilead Sciences, Inc. | 24.33B |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| Amgen, Inc. | 27.78B |
| REGENXBIO, Inc. | 135.34M |